ciprofloxacin has been researched along with kanamycin a in 89 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (2.25) | 18.7374 |
1990's | 4 (4.49) | 18.2507 |
2000's | 30 (33.71) | 29.6817 |
2010's | 45 (50.56) | 24.3611 |
2020's | 8 (8.99) | 2.80 |
Authors | Studies |
---|---|
Sriram, D; Thirumurugan, R; Yogeeswari, P | 1 |
Christiansen, HC; Copp, BR; G Franzblau, S; Lindsay, BS | 1 |
Chen, S; Cui, S; McDermott, PF; Meng, J; Paulsen, I; White, DG; Zhao, S | 1 |
Hall, P; Hudock, MP; Leon, A; Liu, L; Morita, CT; Oldfield, E; Puan, KJ; Studer, D; Yang, Y; Yin, F | 1 |
El'Garch, F; Hocquet, D; Jeannot, K; Llanes-Barakat, C; Plésiat, P | 1 |
Elkins, CA; Mullis, LB | 1 |
Goswami, M; Jawali, N; Mangoli, SH | 1 |
Barth, AL; Castanheira, M; Gales, AC; Nicoletti, AG; Pereira, AS; Pignatari, AC | 1 |
Kwon, DH; Lu, CD | 1 |
Courvalin, P; Galimand, M; Périchon, B | 1 |
Castanheira, M; Jones, RN; Mendes, RE; Sader, HS; Toleman, MA; Walsh, TR | 1 |
Chen, YT; Lauderdale, TL; Liao, TL; Shiau, YR; Shu, HY; Su, IJ; Tsai, SF; Wu, KM; Yan, JJ | 1 |
Arakawa, Y; Kato, H; Kimura, K; Konda, T; Shibata, N; Shibayama, K; Suzuki, S; Wachino, J; Yamane, K | 1 |
Liu, Y; Shi, W; Wang, M; Wu, S; Xu, X; Ye, X; Zhang, Y | 1 |
Andres, P; Centrón, D; Galas, M; Guerriero, L; Petroni, A; Quiroga, C; Quiroga, MP; Soler Bistué, AJ; Tokumoto, M; Tolmasky, ME; Vargas, LJ; Zorreguieta, A | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Jeon, B; Muraoka, W; Sahin, O; Zhang, Q | 1 |
Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L | 1 |
Bammert, GF; Banitt, LS; Barbachyn, MR; Boyle, TP; Bundy, GL; Dolak, LA; Ford, CW; Graber, DR; Hamel, JC; Han, F; Harris, DW; Hromockyj, AE; Hurd, AR; Kamilar, GM; Marotti, KR; Martin, GE; Miller, AA; Mott, JE; Munzner, JB; Palmer, JR; Ruble, JC; Seest, EP; Skepner, JE; Sweeney, MT; Zhong, WZ; Zurenko, GE | 1 |
Andersson, DI; Negrea, A; Pränting, M; Rhen, M | 1 |
Connell, TG; Curtis, N; Ritz, N; Robins-Browne, R; Sievers, A; Tebruegge, M | 1 |
Ike, Y; Inoue, T; Tomita, H; Zheng, B | 1 |
Wang, X; Zhao, X | 1 |
Gaillard, JL; Jackson, M; McDonnell, G; Niederweis, M; Skovierová, H; Svetlíková, Z | 1 |
Buchholz, F; Harms, H; Lerchner, J; Maskow, T; Mertens, F; Wolf, A | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Elkins, CA; Jung, CM; Lacher, DW; Mullis, LB | 1 |
Bavari, S; Bowlin, TL; Houseweart, C; Moir, DT; Opperman, TJ; Panchal, RG; Peet, NP; Williams, JD | 1 |
Blango, MG; Mulvey, MA | 1 |
Mima, T; Schweizer, HP | 1 |
Goswami, M; Jawali, N | 1 |
Bohnert, JA; Karamian, B; Nikaido, H | 1 |
Bogaerts, P; Buvens, G; Glupczynski, Y; Lauwers, S; Piérard, D | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Kalle, AM; Rizvi, A | 1 |
Chiba, T; Hasegawa, T; Horita, Y; Kremer, L; Kuroishi, R; Lee, Y; Ogawa, K; Onozaki, K; Sato, Y; Takii, T | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Cai, G; Cho, S; Franzblau, SG; Jaki, BU; Lee, IA; McAlpine, JB; Napolitano, JG; Pauli, GF; Suh, JW; Wang, Y; Yang, SH | 1 |
Alam, MZ; Bruhn, DF; Feng, L; Hurdle, JG; Lee, RB; Lee, RE; Maddox, MM; Narula, G; Sandhaus, S; Simmons, CJ; Sun, D; Tse-Dinh, YC; Tsutsumi, LS; Wu, X | 1 |
Deering, RW; Mincer, TJ; Poulson-Ellestad, KL; Rowley, DC; Whalen, KE | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Blair, PM; Mitchell, DA; Molloy, EM; Tietz, JI | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Brozovic, A; Dowson, CG; Gazvoda, M; Košmrlj, J; Lloyd, A; Osmak, M; Proud, C; Roper, DI; Vajs, J | 1 |
Baasov, T; Belakhov, V; Pokrovskaya, V; Shavit, M | 1 |
Ashenden, S; Bender, A; Cokol, M; Karakoc, I; Kuru, N; Mason, DJ; Meral, S; Stott, I; Weinstein, ZB | 1 |
Domalaon, R; Gorityala, BK; Goswami, S; Idowu, T; Lyu, Y; Schweizer, F; Shan, A; Yang, X; Zhanel, GG | 1 |
Sandargo, B; Stadler, M; Surup, F; Thongbai, B | 1 |
Bukhari, SNA; Mallesha, N; Manukumar, HM; Qin, HL; Rakesh, KP; Vivek, HK; Wang, SM; Zha, GF | 1 |
Bai, L; Deng, JL; Gao, F; Lv, ZS; Wang, Y; Xu, Z; Zhang, F; Zhao, SJ | 1 |
Zhang, B | 1 |
Cheng, T; Chepkirui, C; Decock, C; Matasyoh, JC; Stadler, M | 1 |
Gao, F; Huang, G; Wang, T; Xiao, J | 1 |
Bera, S; Mondal, D | 1 |
Ba, Y; Hou, X; Wang, S; Xu, Z; Yang, H; Zhang, J | 1 |
Ba, Z; Chang, L; Gou, S; Li, B; Liu, H; Ni, J; Ouyang, X; Zhang, J; Zhang, T; Zhang, Y; Zhong, C; Zhu, N; Zhu, Y | 1 |
Guo, Y; Jia, G; Li, L; Wang, J; Wei, L; Xu, X; Yang, Y; Yu, Q; Zhou, Y | 1 |
Lohan, S; Mohammed, EHM; Parang, K; Tiwari, RK | 1 |
Angeles-Solano, M; Brock, JW; Grosser, MR; Murphy, KE; Pugh, BA; Rao, AB; Wolfe, AL | 1 |
Rahal, JJ; Simberkoff, MS | 1 |
Bayer, AS; Kim, KS | 1 |
Maezawa, H; Nakazawa, Y; Saito, A; Sakai, O; Sakamoto, M; Saruta, K; Shiba, K; Shindo, N; Yoshida, M; Yoshikawa, K | 1 |
Arana, I; Barcina, I; Fernández-Astorga, A; Muela, A; Pocino, M | 1 |
Gwanzura, L; Katzenstein, DA; Latif, AS; Marowa, E; Mason, PR; Ray, S | 1 |
Beck, R; Drewelow, B; Guthoff, R; Hehl, EM; Luthard, K | 1 |
Domínguez, L; Fernández-Garayzábal, JF; Latre, MV; Moreno, MA; Rodríguez, AA; Vela, AI | 1 |
Carbonell, D; Fernández-Olivera, N; García-García, I; López-Saura, PA; Machado-Molina, D; Milanés-Virelles, MT; Suárez-Méndez, R; Valdés-Quintana, M; Valenzuela-Silva, CM | 1 |
Andrianasolo, D; Ramarokoto, H; Ramaroson, F; Rasolofo Razanamparany, V; Rasolonavalona, T; Ratsimba, L; Razafitsiarovana, I; Vincent, V | 1 |
Arjratanakool, W; Asawapokee, N; Chaiprasert, A; Dhiraputra, C; Leechawengwong, M; Leelarasamee, A; Prammananan, T; Tingtoy, N | 1 |
Chida, K; Fujita, K; Hayakawa, H; Nakamura, Y; Nakano, Y; Shirai, M; Suda, T | 1 |
Babayan, K; Fenichiu, O; Gaboulaud, V; Hovhannisyan, G; von Schoen-Angerer, T | 1 |
Campbell, PJ; Cowan, LS; Dalton, TL; Hooks, DP; Metchock, B; Morlock, GP; Plikaytis, BB; Posey, JE; Sikes, RD; Starks, AM | 1 |
Becket, E; Kang, TM; Miller, JH; Nguyen, A; Yang, H; Yuan, J | 1 |
Muzyka, N; Oktyabrsky, O; Samoilova, Z; Smirnova, G | 1 |
Kuete, V; Tane, P; Tankeo, SB | 1 |
Allnutt, JC; Bacon, J; Bottley, G; Doris, KS; Hatch, KA; Hendon-Dunn, CL; Marriott, AA; Marsh, PD; Taylor, SC; Thomas, SR; Watson, RJ | 1 |
Brooke, JS; Chanyi, RM; Koval, SF | 1 |
Ghasemi, Y; Mehraban, MH; Moosavi-Movahedi, AA; Motovali-Bashi, M; Odooli, S; Roghanian, R; Yousefi, R | 1 |
Bezmaternykh, K; Oktyabrsky, ON; Smirnova, G | 1 |
Bloodworth, RA; Cardona, ST; Choy, M; Gislason, AS; Li, X; Qu, W; Stietz, MS; Zhang, C | 1 |
Jia, H; Li, B; Li, Y; Liu, K; Ma, L; Ma, Z; Qiu, Y; Shao, D; Shi, Y; Wei, J | 1 |
Carr, AN; Cho, J; Johnson, B; Whitworth, L; Wilson, KS | 1 |
Odoi, A; Oguttu, JW; Qekwana, DN; Sithole, F | 1 |
Kim, KS; Lee, J; Lee, YR; Magar, KBS; Shin, J | 1 |
Anderson, EM; Barnett Foster, DE; Khursigara, CM; Park, AJ; Puño-Sarmiento, J | 1 |
Bezmaternykh, KV; Oktyabrsky, ON; Smirnova, GV; Tyulenev, AV | 1 |
Hassan Kaviar, V; Khadivar, P; Kouhsari, E; Maleki, A; Omidi, N; Vaziri, AZ; Wu, Q | 1 |
Garza-Cervantes, JA; León-Buitimea, A; Mendiola-Garza, G; Morones-Ramírez, JR | 1 |
7 review(s) available for ciprofloxacin and kanamycin a
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Fluoroquinolone-isatin hybrids and their biological activities.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Antitubercular Agents; Antiviral Agents; Fluoroquinolones; Humans; Isatin; Structure-Activity Relationship | 2019 |
Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles | 2019 |
Antibacterial activity study of 1,2,4-triazole derivatives.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles | 2019 |
Insights of synthetic analogues of anti-leprosy agents.
Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship | 2019 |
Nitroimidazole-containing compounds and their antibacterial and antitubercular activities.
Topics: Anti-Bacterial Agents; Bacterial Infections; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Nitroimidazoles | 2019 |
Antimicrobial resistance among clinical
Topics: Anti-Bacterial Agents; Chloramphenicol; Cholera; Ciprofloxacin; Drug Resistance, Bacterial; Erythromycin; Gentamicins; Humans; Kanamycin; Microbial Sensitivity Tests; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vibrio cholerae non-O1 | 2023 |
3 trial(s) available for ciprofloxacin and kanamycin a
Article | Year |
---|---|
Sepsis associated with hematological malignancies: prophylaxis of Pseudomonas aeruginosa sepsis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Bacteremia; Ciprofloxacin; Drug Therapy, Combination; Female; Humans; Kanamycin; Leukemia; Lymphoma; Male; Middle Aged; Polymyxin B; Pseudomonas Infections; Retrospective Studies | 1996 |
Improved penetration of aminoglycosides and fluorozuinolones into the aqueous humour of patients by means of Acuvue contact lenses.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Aqueous Humor; Ciprofloxacin; Contact Lenses, Hydrophilic; Drug Delivery Systems; Eye Infections; Female; Gentamicins; Humans; Kanamycin; Male; Middle Aged; Ofloxacin; Ophthalmic Solutions; Staphylococcus epidermidis; Tobramycin | 1999 |
Adjuvant interferon gamma in patients with drug - resistant pulmonary tuberculosis: a pilot study.
Topics: Adjuvants, Immunologic; Adult; Amikacin; Antitubercular Agents; Ciprofloxacin; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Follow-Up Studies; Humans; Interferon-gamma; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Pilot Projects; Pyrazinamide; Radiography; Recombinant Proteins; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2004 |
79 other study(ies) available for ciprofloxacin and kanamycin a
Article | Year |
---|---|
Antituberculous activity of some aryl semicarbazone derivatives.
Topics: Antitubercular Agents; Microbial Sensitivity Tests; Molecular Conformation; Molecular Structure; Mycobacterium tuberculosis; Semicarbazones; Structure-Activity Relationship | 2004 |
Identification of heteroarylenamines as a new class of antituberculosis lead molecules.
Topics: Amines; Antitubercular Agents; Drug Evaluation, Preclinical; Drug Resistance; Inhibitory Concentration 50; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2005 |
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
Topics: Animals; Anti-Infective Agents; DNA Topoisomerases; Drug Resistance, Bacterial; Fluoroquinolones; Gene Targeting; Genes, Bacterial; Mutation; Salmonella Infections, Animal; Salmonella typhimurium | 2007 |
Isoprenoid biosynthesis as a drug target: bisphosphonate inhibition of Escherichia coli K12 growth and synergistic effects of fosmidomycin.
Topics: Anti-Bacterial Agents; Cluster Analysis; Diphosphonates; Drug Synergism; Escherichia coli K12; Fosfomycin; Gene Expression; Geranyltranstransferase; Models, Molecular; Oligonucleotide Array Sequence Analysis; Quantitative Structure-Activity Relationship; Terpenes | 2006 |
Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.
Topics: Aminoglycosides; Anti-Bacterial Agents; Biological Evolution; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Bacterial; Gene Silencing; Genes, Bacterial; Microbial Sensitivity Tests; Mutagenesis, Insertional; Mutation; Pseudomonas aeruginosa; Reverse Transcriptase Polymerase Chain Reaction | 2007 |
Substrate competition studies using whole-cell accumulation assays with the major tripartite multidrug efflux pumps of Escherichia coli.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Binding, Competitive; Carrier Proteins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Indicators and Reagents; Microbial Sensitivity Tests; Progesterone; Steroids | 2007 |
Effects of glutathione and ascorbic acid on streptomycin sensitivity of Escherichia coli.
Topics: Anti-Bacterial Agents; Antioxidants; Ascorbic Acid; Catalase; Escherichia coli; Glutathione; Indicators and Reagents; Nitroblue Tetrazolium; Peroxidases; Peroxiredoxins; Reactive Oxygen Species; Streptomycin; Superoxide Dismutase | 2007 |
First report of plasmid-mediated qnrA1 in a ciprofloxacin-resistant Escherichia coli strain in Latin America.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Conjugation, Genetic; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Integrons; Latin America; Molecular Sequence Data; Plasmids | 2007 |
Polyamine effects on antibiotic susceptibility in bacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Drug Resistance, Bacterial; Drug Synergism; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Polyamines; Spermine; Staphylococcus aureus | 2007 |
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
Topics: Amino Acid Motifs; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Conjugation, Genetic; Conserved Sequence; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Genes, rRNA; Methylation; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Norfloxacin; Plasmids; Sequence Analysis, DNA; Sequence Homology, Amino Acid | 2007 |
Characterization of an integron carrying blaIMP-1 and a new aminoglycoside resistance gene, aac(6')-31, and its dissemination among genetically unrelated clinical isolates in a Brazilian hospital.
Topics: Acinetobacter; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Base Sequence; Brazil; Codon, Terminator; Cross Infection; Drug Resistance, Multiple, Bacterial; Gene Transfer, Horizontal; Genes, Bacterial; Hospitals; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Open Reading Frames; Plasmids; Pseudomonas putida; Transcription, Genetic | 2007 |
Sequencing and comparative genomic analysis of pK29, a 269-kilobase conjugative plasmid encoding CMY-8 and CTX-M-3 beta-lactamases in Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Conjugation, Genetic; Genomics; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA | 2007 |
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chitosan; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Malates; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Transformation, Bacterial; Uncoupling Agents | 2007 |
Prevalence and expression of the plasmid-mediated quinolone resistance determinant qnrA1.
Topics: Anti-Infective Agents; Base Sequence; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae; Gene Expression Regulation, Bacterial; Genes, Bacterial; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Promoter Regions, Genetic; Quinolones; Reverse Transcriptase Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid | 2007 |
Complex class 1 integrons with diverse variable regions, including aac(6')-Ib-cr, and a novel allele, qnrB10, associated with ISCR1 in clinical enterobacterial isolates from Argentina.
Topics: Alleles; Amino Acid Sequence; Argentina; Bacterial Proteins; Base Sequence; beta-Lactamases; Cross Infection; DNA Transposable Elements; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Role of Cj1211 in natural transformation and transfer of antibiotic resistance determinants in Campylobacter jejuni.
Topics: Amino Acid Sequence; Bacterial Proteins; Base Sequence; Campylobacter jejuni; Drug Resistance, Microbial; Fluoroquinolones; Gene Transfer, Horizontal; Genetic Complementation Test; Kanamycin; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Sequence Homology, Amino Acid; Tetracycline; Transformation, Bacterial | 2008 |
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey | 2008 |
Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Bacteria; Bacterial Infections; Bacterial Proteins; Cell Line; Cell Proliferation; Metabolic Clearance Rate; Mice; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Stereoisomerism; Topoisomerase II Inhibitors | 2008 |
Mechanism and fitness costs of PR-39 resistance in Salmonella enterica serovar Typhimurium LT2.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacterial Proteins; Cathelicidins; Drug Resistance, Multiple, Bacterial; Female; Genetic Complementation Test; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Models, Genetic; Mutagenesis, Insertional; Mutation; Salmonella Infections, Animal; Salmonella typhimurium; Sequence Deletion | 2008 |
Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.
Topics: Antitubercular Agents; BCG Vaccine; Microbial Sensitivity Tests; Mycobacterium bovis | 2009 |
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Bacteriocins; Blotting, Southern; Conjugation, Genetic; Cross Infection; Culture Media; DNA Nucleotidyltransferases; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Erythromycin; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Perforin; Pheromones; Plasmids; Vancomycin Resistance | 2009 |
Contribution of oxidative damage to antimicrobial lethality.
Topics: 2,2'-Dipyridyl; Anti-Bacterial Agents; Bacterial Proteins; Catalase; Escherichia coli; Escherichia coli Proteins; Hydroxyl Radical; Microbial Sensitivity Tests; Norfloxacin; Oxidative Stress; Superoxide Dismutase; Thiourea | 2009 |
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
Topics: Antitubercular Agents; Disinfectants; Drug Resistance, Bacterial; Glutaral; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Mycobacterium chelonae; Mycobacterium smegmatis; o-Phthalaldehyde; Porins | 2009 |
Chip calorimetry for fast and reliable evaluation of bactericidal and bacteriostatic treatments of biofilms.
Topics: 2,4-Dinitrophenol; Adenosine Triphosphate; Anti-Bacterial Agents; Biofilms; Calorimetry; Ciprofloxacin; Formaldehyde; Kanamycin; Microbial Sensitivity Tests; Microcomputers; Pseudomonas putida; Tetracycline | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Single nucleotide polymorphism analysis of the major tripartite multidrug efflux pump of Escherichia coli: functional conservation in disparate animal reservoirs despite exposure to antimicrobial chemotherapy.
Topics: Animals; Anti-Bacterial Agents; Catfishes; Cattle; Disease Reservoirs; Escherichia coli; Escherichia coli Proteins; Feces; Gene Expression Regulation, Bacterial; Intestines; Mice; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Mutation; Phylogeny; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Rats; Recombination, Genetic; Sequence Analysis, DNA; Structure-Activity Relationship | 2010 |
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
Topics: Bacterial Proteins; Drug Resistance, Bacterial; Indoles; Microbial Sensitivity Tests; Mutation; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcus aureus; Structure-Activity Relationship; Substrate Specificity | 2010 |
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Membrane Permeability; Cells, Cultured; Drug Resistance, Bacterial; Endosomes; Escherichia coli; Escherichia coli Infections; Female; Humans; Mice; Mice, Inbred CBA; Microbial Sensitivity Tests; Recurrence; Urinary Bladder; Urinary Tract Infections; Urothelium | 2010 |
The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Burkholderia pseudomallei; Culture Media; Drug Resistance, Multiple, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Periplasmic Proteins; Quorum Sensing; Singapore; Virulence Factors | 2010 |
N-acetylcysteine-mediated modulation of bacterial antibiotic susceptibility.
Topics: Acetylcysteine; Anti-Bacterial Agents; Culture Media; Drug Resistance, Bacterial; Expectorants; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests | 2010 |
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates.
Topics: Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chlortetracycline; Dipeptides; Doxorubicin; Doxycycline; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Minocycline; Onium Compounds; Organophosphorus Compounds; Tetracycline | 2010 |
Antimicrobial resistance testing of verocytotoxin-producing Escherichia coli and first description of TEM-52 extended-spectrum β-lactamase in serogroup O26.
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Humans; Plasmids; Shiga Toxins | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Inhibition of bacterial multidrug resistance by celecoxib, a cyclooxygenase-2 inhibitor.
Topics: Ampicillin; Celecoxib; Chloramphenicol; Ciprofloxacin; Cyclooxygenase 2 Inhibitors; Drug Resistance, Multiple, Bacterial; Kanamycin; Microbial Sensitivity Tests; Mycobacterium smegmatis; Pyrazoles; Staphylococcus aureus; Sulfonamides | 2011 |
Synthesis and evaluation of anti-tubercular activity of new dithiocarbamate sugar derivatives.
Topics: Antitubercular Agents; Carbohydrates; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxidoreductases; Thiocarbamates; Thioglucosides | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Chromatography, High Pressure Liquid; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic; Streptomyces; Vero Cells | 2013 |
Synthesis, structure-activity relationship studies, and antibacterial evaluation of 4-chromanones and chalcones, as well as olympicin A and derivatives.
Topics: Animals; Anti-Bacterial Agents; Chalcones; Chemistry Techniques, Synthetic; Chlorocebus aethiops; Chromones; DNA Gyrase; DNA Topoisomerase IV; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phloroglucinol; Structure-Activity Relationship; Topoisomerase II Inhibitors; Vero Cells | 2014 |
Enhancement of antibiotic activity against multidrug-resistant bacteria by the efflux pump inhibitor 3,4-dibromopyrrole-2,5-dione isolated from a Pseudoalteromonas sp.
Topics: Anti-Bacterial Agents; Benzimidazoles; Drug Resistance, Multiple; Fluorescent Dyes; Gram-Negative Bacteria; Membrane Transport Proteins; Metabolomics; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Pseudoalteromonas; Pseudomonas aeruginosa; Pyrroles | 2015 |
Biological characterization of the hygrobafilomycin antibiotic JBIR-100 and bioinformatic insights into the hygrolide family of natural products.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Biological Products; Computational Biology; Dose-Response Relationship, Drug; Fungi; Macrolides; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2016 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Diaryltriazenes as antibacterial agents against methicillin resistant Staphylococcus aureus (MRSA) and Mycobacterium smegmatis.
Topics: Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium smegmatis; Triazenes | 2017 |
Covalently linked kanamycin - Ciprofloxacin hybrid antibiotics as a tool to fight bacterial resistance.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Kanamycin; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2017 |
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.
Topics: Anti-Bacterial Agents; Drug Interactions; Molecular Structure | 2017 |
Amphiphilic Tobramycin-Lysine Conjugates Sensitize Multidrug Resistant Gram-Negative Bacteria to Rifampicin and Minocycline.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Hemolysis; Lysine; Microbial Sensitivity Tests; Minocycline; Models, Biological; Rifampin; Tobramycin | 2017 |
Cysteine-Derived Pleurotin Congeners from the Nematode-Trapping Basidiomycete Hohenbuehelia grisea.
Topics: Acetylcysteine; Agaricales; Animals; Anti-Infective Agents; Basidiomycota; Cysteine; Fungi; Heterocyclic Compounds, 4 or More Rings; Magnetic Resonance Spectroscopy; Nematoda; Sulfhydryl Compounds; Sulfur; Thailand | 2018 |
Discovery of novel arylethenesulfonyl fluorides as potential candidates against methicillin-resistant of Staphylococcus aureus (MRSA) for overcoming multidrug resistance of bacterial infections.
Topics: Bacterial Infections; Biofilms; Drug Resistance, Multiple; Electron Transport Chain Complex Proteins; Fluorides; Methicillin-Resistant Staphylococcus aureus; Molecular Docking Simulation; Oxidation-Reduction; Staphylococcal Infections; Sulfinic Acids; Sulfones | 2019 |
Sesquiterpenes from an Eastern African Medicinal Mushroom Belonging to the Genus Sanghuangporus.
Topics: Africa, Eastern; Agaricales; Anti-Infective Agents; Antibiotics, Antineoplastic; Bacteria; Basidiomycota; Cell Line, Tumor; Drug Screening Assays, Antitumor; Fermentation; Fungi; Humans; Kenya; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Structure; Sesquiterpenes; Tandem Mass Spectrometry | 2019 |
Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Antineoplastic Agents; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Pneumonia, Bacterial; Pore Forming Cytotoxic Proteins; Structure-Activity Relationship; Wasp Venoms | 2021 |
Metallo-β-lactamases inhibitor fisetin attenuates meropenem resistance in NDM-1-producing Escherichia coli.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Escherichia coli; Flavonols; Meropenem; Microbial Sensitivity Tests | 2022 |
Amphiphilic cyclic peptide [W
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Gram-Negative Bacteria; Gram-Positive Bacteria; Meropenem; Microbial Sensitivity Tests; Peptides, Cyclic; Pseudomonas aeruginosa | 2022 |
Design and evaluation of poly-nitrogenous adjuvants capable of potentiating antibiotics in Gram-negative bacteria.
Topics: | 2022 |
Bactericidal activity of ciprofloxacin against amikacin- and cefotaxime-resistant gram-negative bacilli and methicillin-resistant staphylococci.
Topics: Amikacin; Cefotaxime; Ciprofloxacin; Cross Infection; Gram-Negative Bacteria; Humans; Kanamycin; Methicillin; Penicillin Resistance; Quinolines; Staphylococcus | 1986 |
In vivo efficacy of azlocillin and amikacin versus ciprofloxacin with and without amikacin in experimental right-sided endocarditis due to Pseudomonas aeruginosa.
Topics: Amikacin; Animals; Azlocillin; Ciprofloxacin; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Kanamycin; Penicillin Resistance; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Rabbits; Time Factors | 1986 |
Detection and enumeration of viable but non-culturable transconjugants of Escherichia coli during the survival of recipient cells in river water.
Topics: Ciprofloxacin; Colony Count, Microbial; Conjugation, Genetic; Escherichia coli; Fresh Water; Kanamycin; Streptomycin | 1997 |
Antimicrobial resistance in gonococci isolated from patients and from commercial sex workers in Harare, Zimbabwe.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactam Resistance; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Female; Gonorrhea; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin; Penicillinase; Sex Work; Zimbabwe | 1997 |
Antimicrobial susceptibility of Listeria monocytogenes isolated from meningoencephalitis in sheep.
Topics: Amoxicillin; Animal Feed; Animals; Anti-Bacterial Agents; Brain; Cephalosporins; Cephalothin; Chloramphenicol; Ciprofloxacin; Doxycycline; Drug Resistance, Microbial; Erythromycin; Gentamicins; Kanamycin; Listeria monocytogenes; Listeriosis; Meningoencephalitis; Microbial Sensitivity Tests; Penicillin G; Penicillins; Rifampin; Sheep; Sheep Diseases; Sulfisoxazole; Tetracycline; Trimethoprim; Vancomycin | 2001 |
[A case of pulmonary multiresistant Mycobacterium bovis tuberculosis in Madagascar].
Topics: Amikacin; Antitubercular Agents; Capreomycin; Chronic Disease; Ciprofloxacin; Cough; DNA, Bacterial; Drug Therapy, Combination; Ethionamide; Humans; Kanamycin; Madagascar; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium bovis; Ofloxacin; Patient Compliance; Polymorphism, Restriction Fragment Length; Sputum; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2003 |
Second-line drug susceptibilities of Thai multidrug-resistant Mycobacterium tuberculosis isolates.
Topics: Amikacin; Aminosalicylic Acid; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Ethionamide; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Thailand | 2005 |
[A case of severe intestinal tuberculosis, treated with ciprofloxacin, kanamycin and prednisolone].
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Ciprofloxacin; Drug Therapy, Combination; Humans; Kanamycin; Male; Prednisolone; Tuberculosis, Gastrointestinal | 2006 |
Antimicrobial susceptibility of Neisseria gonorrheae strains in three regions of Armenia.
Topics: Anti-Bacterial Agents; Armenia; Ciprofloxacin; Doxycycline; Gonorrhea; Humans; Kanamycin; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Ofloxacin; Penicillins | 2007 |
Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.
Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; Ciprofloxacin; Ethambutol; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Rifampin | 2011 |
The aminoglycoside antibiotic kanamycin damages DNA bases in Escherichia coli: caffeine potentiates the DNA-damaging effects of kanamycin while suppressing cell killing by ciprofloxacin in Escherichia coli and Bacillus anthracis.
Topics: Bacillus anthracis; Caffeine; Ciprofloxacin; DNA Damage; Drug Interactions; Escherichia coli; Kanamycin | 2012 |
Influence of plant polyphenols and medicinal plant extracts on antibiotic susceptibility of Escherichia coli.
Topics: Anti-Bacterial Agents; beta-Galactosidase; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Herb-Drug Interactions; Kanamycin; Microbial Sensitivity Tests; Plant Extracts; Plants, Medicinal; Polyphenols; Quercetin | 2012 |
In vitro antibacterial and antibiotic-potentiation activities of the methanol extracts from Beilschmiedia acuta, Clausena anisata, Newbouldia laevis and Polyscias fulva against multidrug-resistant Gram-negative bacteria.
Topics: Anti-Bacterial Agents; Araliaceae; Bignoniaceae; Ciprofloxacin; Clausena; Drug Resistance, Multiple, Bacterial; Drug Synergism; Gram-Negative Bacteria; Kanamycin; Lauraceae; Methanol; Microbial Sensitivity Tests; Plant Extracts; Plant Leaves; Rutaceae; Tetracycline | 2015 |
A Flow Cytometry Method for Rapidly Assessing Mycobacterium tuberculosis Responses to Antibiotics with Different Modes of Action.
Topics: Antitubercular Agents; Ciprofloxacin; Flow Cytometry; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin | 2016 |
Stenotrophomonas maltophilia biofilm reduction by Bdellovibrio exovorus.
Topics: Anti-Bacterial Agents; Antibiosis; Bdellovibrio; Biofilms; Ciprofloxacin; Environmental Microbiology; Gram-Negative Bacterial Infections; Humans; Kanamycin; Sewage; Stenotrophomonas maltophilia | 2016 |
The interaction of beta-lactoglobulin with ciprofloxacin and kanamycin; a spectroscopic and molecular modeling approach.
Topics: Binding Sites; Ciprofloxacin; Drug Delivery Systems; Humans; Hydrophobic and Hydrophilic Interactions; Kanamycin; Lactoglobulins; Molecular Docking Simulation; Protein Binding | 2017 |
The effect of 20-hydroxyecdysone on the susceptibility of Escherichia coli to different antibiotics.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Interactions; Ecdysterone; Escherichia coli; Gene Expression; Kanamycin; SOS Response, Genetics | 2016 |
Competitive Growth Enhances Conditional Growth Mutant Sensitivity to Antibiotics and Exposes a Two-Component System as an Emerging Antibacterial Target in Burkholderia cenocepacia.
Topics: Anti-Bacterial Agents; Burkholderia cenocepacia; Chloramphenicol; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Hydrazones; Kanamycin; Meropenem; Microbial Sensitivity Tests; Novobiocin; Tetracycline; Thienamycins | 2017 |
Antimicrobial Resistance of Campylobacter Species Isolated from Broilers in Live Bird Markets in Shanghai, China.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Campylobacter coli; Campylobacter jejuni; Carrier Proteins; Chickens; China; Ciprofloxacin; Clindamycin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Erythromycin; Food Contamination; Food Microbiology; Gentamicins; Kanamycin; Methyltransferases; Microbial Sensitivity Tests; Poultry; Quinolones; RNA, Ribosomal, 23S; Tetracyclines | 2017 |
MazEF toxin-antitoxin proteins alter Escherichia coli cell morphology and infrastructure during persister formation and regrowth.
Topics: Ampicillin; Anti-Bacterial Agents; Cell Division; Chloramphenicol; Ciprofloxacin; DNA Replication; DNA-Binding Proteins; DNA, Bacterial; Endoribonucleases; Escherichia coli; Escherichia coli Proteins; Kanamycin; Microscopy, Electron | 2017 |
Patterns and predictors of antimicrobial resistance among Staphylococcus spp. from canine clinical cases presented at a veterinary academic hospital in South Africa.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Dog Diseases; Dogs; Doxycycline; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Enrofloxacin; Female; Fluoroquinolones; Hospitals, Animal; Kanamycin; Lincomycin; Male; Retrospective Studies; South Africa; Spectinomycin; Staphylococcal Infections; Staphylococcus; Trimethoprim, Sulfamethoxazole Drug Combination; Tylosin | 2017 |
Design, synthesis, and discovery of novel oxindoles bearing 3-heterocycles as species-specific and combinatorial agents in eradicating Staphylococcus species.
Topics: Ciprofloxacin; Drug Design; Drug Discovery; Drug Resistance, Multiple; Gentamicins; Humans; Kanamycin; Molecular Structure; Oxindoles; Species Specificity; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Structure-Activity Relationship | 2019 |
Potentiation of Antibiotics by a Novel Antimicrobial Peptide against Shiga Toxin Producing E. coli O157:H7.
Topics: Anti-Bacterial Agents; Chloramphenicol; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Escherichia coli Infections; Escherichia coli O157; Gentamicins; Humans; Kanamycin; Meropenem; Microbial Sensitivity Tests; Pore Forming Cytotoxic Proteins; Real-Time Polymerase Chain Reaction | 2020 |
Effect of resveratrol and quercetin on the susceptibility of Escherichia coli to antibiotics.
Topics: Anti-Bacterial Agents; Antioxidants; beta-Galactosidase; Cefotaxime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Kanamycin; Oxidative Stress; Plant Extracts; Polyphenols; Quercetin; Resveratrol; Streptomycin; Stress, Physiological | 2020 |
Synergistic antibacterial effects of exopolysaccharides/nickel-nanoparticles composites against multidrug-resistant bacteria.
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Ciprofloxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Kanamycin; Metal Nanoparticles; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nickel; Pseudomonas aeruginosa | 2023 |